Clearmind Medicine Inc (CMND)

$1.00 -0.02 (-1.96%)
Market Cap 5.47M
Revenue (ttm) 0.00
Net Income (ttm) -5.25M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 66,800
Avg Vol 841,500
Day's Range N/A - N/A
Shares Out 5.47M
Stochastic %K 14%
Beta 0.99
Analysts Strong Buy
Price Target N/A

Company Profile

Clearmind Medicine Inc., a clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. It develops treatments for alcohol use disorders, binge drinking, and eating disorders, as well as weight loss, obesity, and metabolic syndrome, anxiety disorders, post-traumatic stress disorder, depression, and treatment resistant depression. The company develops MEAI compound for the treatment of alcohol use disorder, obesity, and metabolic disorders, as well...

Industry: Biotechnology
Sector: Healthcare
Phone: 973 536 1016
Address:
1220 West 6th Avenue, Suite 101, Vancouver, Canada
WhooDey
WhooDey Oct. 3 at 7:38 PM
$CMND
0 · Reply
KStonk14
KStonk14 Oct. 1 at 9:25 PM
$CMND trash
0 · Reply
DOGNUTS1234
DOGNUTS1234 Sep. 30 at 11:39 AM
$CMND They are trapping money now..
0 · Reply
NVDAMillionaire
NVDAMillionaire Sep. 29 at 10:09 PM
$CMND Brilliant piece that captures CMND's situation perfectly. So if you want to update your understanding of CMND or get to know CMND better, this is essential reading. https://beyondspx.com/quote/CMND/analysis/clearmind-medicine-pioneering-psychedelic-therapeutics-for-global-health-challenges-cmnd
0 · Reply
KStonk14
KStonk14 Sep. 29 at 8:45 PM
$CMND scammy trash
0 · Reply
KStonk14
KStonk14 Sep. 26 at 9:43 PM
$CMND trash scam
0 · Reply
DOGNUTS1234
DOGNUTS1234 Sep. 26 at 1:42 PM
$CMND Dead money
0 · Reply
DOGNUTS1234
DOGNUTS1234 Sep. 26 at 12:47 PM
$CMND Where are t h e buyers
0 · Reply
eleal4388
eleal4388 Sep. 26 at 11:33 AM
$CMND lets see some green today. 🤑
0 · Reply
MamaNeedsMoney
MamaNeedsMoney Sep. 26 at 4:36 AM
$CMND I see progress every day here. Just a matter of time.
0 · Reply
Latest News on CMND
Clearmind Medicine's Convenes Inaugural Scientific Advisory Board Meeting to Advance Psychedelic-Derived Therapies

Sep 25, 2025, 7:40 AM EDT - 9 days ago

Clearmind Medicine's Convenes Inaugural Scientific Advisory Board Meeting to Advance Psychedelic-Derived Therapies

Clearmind Medicine Secures $10 million Securities Purchase Agreement to Explore Strategic Opportunities

Sep 19, 2025, 8:20 AM EDT - 15 days ago

Clearmind Medicine Secures $10 million Securities Purchase Agreement to Explore Strategic Opportunities

Clearmind Medicine Announces Publication of International Patent Application for Novel Combination Therapy Targeting Obesity and High Blood Sugar

Aug 7, 2025, 7:32 AM EDT - 2 months ago

Clearmind Medicine Announces Publication of International Patent Application for Novel Combination Therapy Targeting Obesity and High Blood Sugar

Clearmind Medicine Receives IRB Approval for Phase 1/2a Clinical Trial for Alcohol Use Disorder at Hadassah Medical Center

Aug 5, 2025, 8:15 AM EDT - 2 months ago

Clearmind Medicine Receives IRB Approval for Phase 1/2a Clinical Trial for Alcohol Use Disorder at Hadassah Medical Center

Clearmind Medicine Files International Patent Application for Novel Combination Therapy Targeting Weight Loss and Fatty Liver Disease

Jul 30, 2025, 8:18 AM EDT - 2 months ago

Clearmind Medicine Files International Patent Application for Novel Combination Therapy Targeting Weight Loss and Fatty Liver Disease

Clearmind Medicine Completes Initiation of Leading Israeli Clinical Site for Phase I/IIa Trial of CMND-100 in Alcohol Use Disorder

Jul 23, 2025, 8:55 AM EDT - 2 months ago

Clearmind Medicine Completes Initiation of Leading Israeli Clinical Site for Phase I/IIa Trial of CMND-100 in Alcohol Use Disorder

Clearmind Expands its Clinical Trial for Alcohol Use: New Site Activated and Additional Participant Enrolled

Jul 15, 2025, 8:05 AM EDT - 2 months ago

Clearmind Expands its Clinical Trial for Alcohol Use: New Site Activated and Additional Participant Enrolled

Clearmind Medicine Announces IRB Approval for Phase 1/2a Clinical Trial for Alcohol Use Disorder at Tel Aviv Sourasky Medical Center

Jul 3, 2025, 8:47 AM EDT - 3 months ago

Clearmind Medicine Announces IRB Approval for Phase 1/2a Clinical Trial for Alcohol Use Disorder at Tel Aviv Sourasky Medical Center

Clearmind Medicine Announces First Participant Ever Dosed with its CMND-100 Treatment in Groundbreaking Clinical Trial for Alcohol Use Disorder

Jun 30, 2025, 9:16 AM EDT - 3 months ago

Clearmind Medicine Announces First Participant Ever Dosed with its CMND-100 Treatment in Groundbreaking Clinical Trial for Alcohol Use Disorder

Clearmind Medicine Expands Global Clinical Trial Targeting Multibillion-Dollar Alcohol Use Disorder Market

Jun 27, 2025, 9:00 AM EDT - 3 months ago

Clearmind Medicine Expands Global Clinical Trial Targeting Multibillion-Dollar Alcohol Use Disorder Market

Clearmind Medicine Enrolls First Patient in its Clinical Trial for Alcoholism Treatment

Jun 25, 2025, 7:48 AM EDT - 3 months ago

Clearmind Medicine Enrolls First Patient in its Clinical Trial for Alcoholism Treatment

Clearmind Medicine Joins Forces with Leading US Political Firm to Promote Psychedelic Therapeutics

Jun 24, 2025, 8:06 AM EDT - 3 months ago

Clearmind Medicine Joins Forces with Leading US Political Firm to Promote Psychedelic Therapeutics

Clearmind Medicine Adds Leading Israeli Clinical Site to Its Ongoing Clinical Trial for Alcohol Use Disorder

Jun 23, 2025, 7:55 AM EDT - 3 months ago

Clearmind Medicine Adds Leading Israeli Clinical Site to Its Ongoing Clinical Trial for Alcohol Use Disorder

Clearmind Medicine Engages Leading Government and Political Affairs Firm to Advance Psychedelic Therapeutics

Jun 12, 2025, 9:25 AM EDT - 4 months ago

Clearmind Medicine Engages Leading Government and Political Affairs Firm to Advance Psychedelic Therapeutics

Clearmind Medicine Announces Enrollment of First Patient in Phase I/IIa Clinical Trial for Alcohol Use Disorder Treatment

Jun 5, 2025, 7:32 AM EDT - 4 months ago

Clearmind Medicine Announces Enrollment of First Patient in Phase I/IIa Clinical Trial for Alcohol Use Disorder Treatment

Clearmind Medicine to Host Live Webinar “Gazing Through the Crystal Ball” Featuring Leading Psychedelic Experts

May 20, 2025, 9:00 AM EDT - 4 months ago

Clearmind Medicine to Host Live Webinar “Gazing Through the Crystal Ball” Featuring Leading Psychedelic Experts

SciSparc-Clearmind Collaboration Leads to Filing of International Patent Application for Novel Treatment of Anorexia, Bulimia and other Eating Disorders

Apr 25, 2025, 7:59 AM EDT - 5 months ago

SciSparc-Clearmind Collaboration Leads to Filing of International Patent Application for Novel Treatment of Anorexia, Bulimia and other Eating Disorders

SPRC

Clearmind Medicine Files International Patent Application for Novel Treatment of Anorexia, Bulimia and other Eating Disorders

Apr 25, 2025, 7:55 AM EDT - 5 months ago

Clearmind Medicine Files International Patent Application for Novel Treatment of Anorexia, Bulimia and other Eating Disorders

Clearmind Medicine Completes the Initiation of its Alcohol Use Disorder Phase I/IIa Clinical Trial at all Current Clinical Sites

Apr 23, 2025, 8:25 AM EDT - 5 months ago

Clearmind Medicine Completes the Initiation of its Alcohol Use Disorder Phase I/IIa Clinical Trial at all Current Clinical Sites

Clearmind Medicine Receives Notice of Allowance for United States Patent Covering Binge Behavior

Apr 17, 2025, 7:38 AM EDT - 6 months ago

Clearmind Medicine Receives Notice of Allowance for United States Patent Covering Binge Behavior

Clearmind Medicine Launches First U.S. Clinical Site for its FDA-Approved Clinical Trial to Combat Alcoholism

Apr 16, 2025, 8:40 AM EDT - 6 months ago

Clearmind Medicine Launches First U.S. Clinical Site for its FDA-Approved Clinical Trial to Combat Alcoholism

Clearmind Medicine Announces First U.S. Clinical Site Initiation for CMND-100 Clinical Trial in Patients with Alcohol Use Disorder

Apr 10, 2025, 8:25 AM EDT - 6 months ago

Clearmind Medicine Announces First U.S. Clinical Site Initiation for CMND-100 Clinical Trial in Patients with Alcohol Use Disorder

Clearmind Medicine Announces the Publication of International Patent Application for Next-Gen Psychedelic Compounds to Treat Mental Health Disorders

Apr 8, 2025, 6:55 AM EDT - 6 months ago

Clearmind Medicine Announces the Publication of International Patent Application for Next-Gen Psychedelic Compounds to Treat Mental Health Disorders

Clearmind Launches its EDC System to Support its Phase I/II Clinical Trial of its MEAI-Based Treatment

Apr 1, 2025, 8:15 AM EDT - 6 months ago

Clearmind Launches its EDC System to Support its Phase I/II Clinical Trial of its MEAI-Based Treatment

Clearmind Medicine's FDA-Approved Clinical Trial for CMND-100 Moves Forward as Drug Arrives in the U.S., Advancing Toward Key Milestones

Mar 21, 2025, 9:28 AM EDT - 7 months ago

Clearmind Medicine's FDA-Approved Clinical Trial for CMND-100 Moves Forward as Drug Arrives in the U.S., Advancing Toward Key Milestones

Clearmind to Evaluate Intranasal Delivery of Its Psychedelic Drug Combination

Mar 19, 2025, 7:35 AM EDT - 7 months ago

Clearmind to Evaluate Intranasal Delivery of Its Psychedelic Drug Combination

Clearmind Medicine Announces Initiation of First in Human Clinical Trial with CMND-100 in Alcohol Use Disorder Patients

Mar 18, 2025, 7:32 AM EDT - 7 months ago

Clearmind Medicine Announces Initiation of First in Human Clinical Trial with CMND-100 in Alcohol Use Disorder Patients

Clearmind Medicine Announces Publication of Patent for Binge Behavior Psychedelic Combination Treatment in Mexico

Feb 4, 2025, 8:35 AM EST - 8 months ago

Clearmind Medicine Announces Publication of Patent for Binge Behavior Psychedelic Combination Treatment in Mexico

Clearmind Medicine Announces Shareholders Meeting Results

Jan 7, 2025, 9:28 AM EST - 9 months ago

Clearmind Medicine Announces Shareholders Meeting Results

Clearmind Medicine Announces the Publication of European Patent Application for Binge Behavior Psychedelic Combination Treatment

Jan 6, 2025, 8:15 AM EST - 9 months ago

Clearmind Medicine Announces the Publication of European Patent Application for Binge Behavior Psychedelic Combination Treatment

Clearmind Medicine Granted Patent for Binge Behavior Treatment by the Macau International Intellectual Property Office

Jan 2, 2025, 7:45 AM EST - 9 months ago

Clearmind Medicine Granted Patent for Binge Behavior Treatment by the Macau International Intellectual Property Office

Clearmind Medicine Looks to Move Forward with its Novel Psychedelic MEAI- Based Alcohol Substitute

Dec 26, 2024, 6:59 AM EST - 10 months ago

Clearmind Medicine Looks to Move Forward with its Novel Psychedelic MEAI- Based Alcohol Substitute

Clearmind Medicine Receives IRB Approval for its FDA-Regulated Clinical Trial

Dec 24, 2024, 6:55 AM EST - 10 months ago

Clearmind Medicine Receives IRB Approval for its FDA-Regulated Clinical Trial

Clearmind Medicine and Dr Glitter Pty Ltd Sign Term Sheet for Mutual Development of Novel Psychedelic MEAI- Based Alcohol Substitute in ActivCrystal™ Format

Dec 16, 2024, 8:37 AM EST - 10 months ago

Clearmind Medicine and Dr Glitter Pty Ltd Sign Term Sheet for Mutual Development of Novel Psychedelic MEAI- Based Alcohol Substitute in ActivCrystal™ Format

Clearmind Medicine Announces IRB Approval for FDA First-In-Human Clinical Trial of CMND-100 at Second Clinical Site

Oct 10, 2024, 8:07 AM EDT - 1 year ago

Clearmind Medicine Announces IRB Approval for FDA First-In-Human Clinical Trial of CMND-100 at Second Clinical Site

Clearmind Medicine Announces the Notice of an International Patent Application for Pioneering Ibogaine Combination Therapy

Sep 16, 2024, 4:06 PM EDT - 1 year ago

Clearmind Medicine Announces the Notice of an International Patent Application for Pioneering Ibogaine Combination Therapy

Clearmind Medicine and Yissum File International Patent Application for Revolutionary Psychedelic Compounds for PTSD Treatment

Sep 12, 2024, 8:20 AM EDT - 1 year ago

Clearmind Medicine and Yissum File International Patent Application for Revolutionary Psychedelic Compounds for PTSD Treatment

Clearmind Medicine Announces Publication of International Patent Application for Innovative MDMA-Based Combination Treatment

Sep 6, 2024, 7:55 AM EDT - 1 year ago

Clearmind Medicine Announces Publication of International Patent Application for Innovative MDMA-Based Combination Treatment

Clearmind Medicine Announces Publication of its Patent Application for Innovative Ketamine-Based Combination Treatment

Aug 29, 2024, 4:25 PM EDT - 1 year ago

Clearmind Medicine Announces Publication of its Patent Application for Innovative Ketamine-Based Combination Treatment

Clearmind Medicine Granted U.S. Patent Approval for Binge Behavior Treatment

Aug 21, 2024, 4:11 PM EDT - 1 year ago

Clearmind Medicine Granted U.S. Patent Approval for Binge Behavior Treatment

Clearmind Medicine and Yissum Expand Collaboration with International Patent Application for Generation 3.0 Psychedelic Compounds to Treat Mental Disorders

Aug 16, 2024, 4:14 PM EDT - 1 year ago

Clearmind Medicine and Yissum Expand Collaboration with International Patent Application for Generation 3.0 Psychedelic Compounds to Treat Mental Disorders

Clearmind Medicine: New Scientific Publication Shows MEAI's Potential as a Novel Weight Loss Drug

Aug 6, 2024, 8:57 AM EDT - 1 year ago

Clearmind Medicine: New Scientific Publication Shows MEAI's Potential as a Novel Weight Loss Drug

Clearmind Medicine Concludes the Successful Participation in the Psychedelic Medicine – Israel 2024 Conference: Presented Industry Leaders its Groundbreaking Research

Jul 31, 2024, 7:44 AM EDT - 1 year ago

Clearmind Medicine Concludes the Successful Participation in the Psychedelic Medicine – Israel 2024 Conference: Presented Industry Leaders its Groundbreaking Research

Clearmind Medicine Signs an Agreement to Source Manufacturers and Distributors for its Alcohol Substitute Beverage Product

Jul 19, 2024, 7:55 AM EDT - 1 year ago

Clearmind Medicine Signs an Agreement to Source Manufacturers and Distributors for its Alcohol Substitute Beverage Product

Clearmind Medicine Obtains IND Approval from the FDA to Start the Phase I/IIa Clinical Trial with its Innovative Treatment for Alcoholism

Jul 16, 2024, 9:02 AM EDT - 1 year ago

Clearmind Medicine Obtains IND Approval from the FDA to Start the Phase I/IIa Clinical Trial with its Innovative Treatment for Alcoholism

Clearmind Medicine Announces Submission of US Patent Application for Treating Metabolic Syndrome and Weight-loss

Jul 16, 2024, 6:03 AM EDT - 1 year ago

Clearmind Medicine Announces Submission of US Patent Application for Treating Metabolic Syndrome and Weight-loss

Clearmind Medicine to Present Groundbreaking Research at Psychedelic Medicine – Israel 2024 Conference

Jul 12, 2024, 8:02 AM EDT - 1 year ago

Clearmind Medicine to Present Groundbreaking Research at Psychedelic Medicine – Israel 2024 Conference

Clearmind Medicine Granted Patent Approval in Hong Kong for its Binge Behaviors Treatment

Jun 28, 2024, 7:55 AM EDT - 1 year ago

Clearmind Medicine Granted Patent Approval in Hong Kong for its Binge Behaviors Treatment

Clearmind Medicine Secured Exclusive Global Rights to Innovative Psychedelic Compounds for PTSD Treatment

Jun 20, 2024, 7:57 AM EDT - 1 year ago

Clearmind Medicine Secured Exclusive Global Rights to Innovative Psychedelic Compounds for PTSD Treatment

Clearmind Medicine Revolutionizes the $13 Billion NonAlcoholic Beverages Market with its Psychedelic-Based Drink

Jun 11, 2024, 7:44 AM EDT - 1 year ago

Clearmind Medicine Revolutionizes the $13 Billion NonAlcoholic Beverages Market with its Psychedelic-Based Drink

WhooDey
WhooDey Oct. 3 at 7:38 PM
$CMND
0 · Reply
KStonk14
KStonk14 Oct. 1 at 9:25 PM
$CMND trash
0 · Reply
DOGNUTS1234
DOGNUTS1234 Sep. 30 at 11:39 AM
$CMND They are trapping money now..
0 · Reply
NVDAMillionaire
NVDAMillionaire Sep. 29 at 10:09 PM
$CMND Brilliant piece that captures CMND's situation perfectly. So if you want to update your understanding of CMND or get to know CMND better, this is essential reading. https://beyondspx.com/quote/CMND/analysis/clearmind-medicine-pioneering-psychedelic-therapeutics-for-global-health-challenges-cmnd
0 · Reply
KStonk14
KStonk14 Sep. 29 at 8:45 PM
$CMND scammy trash
0 · Reply
KStonk14
KStonk14 Sep. 26 at 9:43 PM
$CMND trash scam
0 · Reply
DOGNUTS1234
DOGNUTS1234 Sep. 26 at 1:42 PM
$CMND Dead money
0 · Reply
DOGNUTS1234
DOGNUTS1234 Sep. 26 at 12:47 PM
$CMND Where are t h e buyers
0 · Reply
eleal4388
eleal4388 Sep. 26 at 11:33 AM
$CMND lets see some green today. 🤑
0 · Reply
MamaNeedsMoney
MamaNeedsMoney Sep. 26 at 4:36 AM
$CMND I see progress every day here. Just a matter of time.
0 · Reply
Takeiteasy30
Takeiteasy30 Sep. 25 at 10:57 PM
$NITO $CMND $SPRC Yup those criminals got no shame - whoever got ,,diamond hands" tactics here can go to the toilet and flush down cash - results is the same as diamond hands those lmao
0 · Reply
TA_Kongen
TA_Kongen Sep. 25 at 8:04 PM
$NITO LOL part of same Israeli scam circle: $CMND $SPRC Incredible scammers here.
0 · Reply
eleal4388
eleal4388 Sep. 25 at 7:22 PM
$CMND
0 · Reply
DOGNUTS1234
DOGNUTS1234 Sep. 25 at 1:38 PM
$CMND
0 · Reply
DOGNUTS1234
DOGNUTS1234 Sep. 25 at 1:37 PM
$CMND F-u-c-
0 · Reply
DOGNUTS1234
DOGNUTS1234 Sep. 25 at 1:37 PM
$CMND feds are holding it back
0 · Reply
DOGNUTS1234
DOGNUTS1234 Sep. 25 at 1:36 PM
$CMND
0 · Reply
DOGNUTS1234
DOGNUTS1234 Sep. 25 at 1:35 PM
$CMND We have a clearmind your holding it down...You corrupt
0 · Reply
DOGNUTS1234
DOGNUTS1234 Sep. 25 at 1:33 PM
$CMND Buy your mushroom
0 · Reply
DOGNUTS1234
DOGNUTS1234 Sep. 25 at 1:33 PM
$CMND This is not OVERPRICED
0 · Reply
DOGNUTS1234
DOGNUTS1234 Sep. 25 at 1:31 PM
$CMND Let's go
0 · Reply
DOGNUTS1234
DOGNUTS1234 Sep. 25 at 1:28 PM
$CMND
0 · Reply